On Monday a company that booked $6.9 million of revenue over the past twelve months announced it was buying a defence business with more than $200 million in annual sales. The buyer is Archer Aviation, listed on the New York Stock Exchange, builder of electric vertical take-off aircraft that do not yet carry paying passengers. The seller is Boeing, and it is parting with three subsidiaries at once: Wisk Aero, the autonomous air taxi developer into which Boeing poured an additional $450 million in January 2022 alone; Insitu, maker of the ScanEagle reconnaissance drone, which Boeing acquired in 2008 for a reported $400 million; and SkyGrid, a software platform for managing traffic in low-altitude airspace.
Archer shares rose as much as a fifth intraday on Monday and closed up twelve percent at $6.26, changing hands pre-market on Tuesday at $6.32. That is the headline, and it is the least interesting number in the whole affair.
The interesting part is in the agreement Archer filed with the Securities and Exchange Commission on Monday. Because that document contains something contracts of this size very rarely contain: no purchase price.
A purchase agreement with no purchase price
The consideration Archer will pay is not defined in the 9 August agreement as an amount. It is defined as a share. At closing, Boeing receives “a number of shares of Class A common stock equal to 19.75% of the shares of the Company’s Class A common stock outstanding as of immediately prior to the date of Closing” — adjusted only for the target companies’ cash position against an agreed target, net of debt and transaction expenses. On top of that come two warrants, each with $100.0 million of notional purchase volume.
The arithmetic makes the point. Archer has roughly 759.6 million shares outstanding. A 19.75 percent issue is about 150 million new shares. At Monday’s close of $6.26 that is worth roughly $940 million. But that figure appears nowhere in the contract. It is a function of the share price on the closing date, which will fall no earlier than year-end and no later than May 2027. If Archer trades at twelve dollars by then, Boeing will have received $1.8 billion for the same three companies. If it trades at four, it will have received $600 million. The share count does not move. Only its value does.
For Archer’s existing holders this is the best available structure, and that deserves to be said plainly. Dilution is fixed at 19.75 percent and cannot be exceeded, whatever the stock does. After closing Boeing will hold 19.75 divided by 119.75 — 16.5 percent of the enlarged company. Anyone who owns Archer today knows to the decimal how much of their stake is being handed over. What they do not know is what was paid for it. The price is the share price, and the contract does not set it.
Why the number is 19.75 percent
The figure looks arbitrary. It is not. Section 312.03(c) of the NYSE Listed Company Manual requires shareholder approval before a listed company issues common stock equal to or in excess of 20 percent of the shares outstanding before the issuance. The carve-outs cover, in substance, public offerings for cash and bona fide private financings above a minimum price. An acquisition paid for in stock fits neither.
19.75 sits exactly a quarter of a point under the line. And the filing itself makes the connection explicit: entry into a further agreement with Boeing is conditioned on the NYSE confirming that those shares will not be aggregated with the consideration shares, and “confirming that the issuance of such shares under the Purchase Agreement would not require approval of the Company’s stockholders.” The warrants carry a matching ceiling — Boeing may not exercise them to a point where it would beneficially own 19.9 percent or more.
So the largest equity issuance in this company’s history was sized not by a valuation but by a listing rule. Shareholders do get their vote — later. Archer must call a special meeting within 60 days of closing to obtain approval for the warrants. If it is not obtained by the date the warrants first become exercisable, they are automatically exchanged for replacement warrants that settle in cash on exercise. Dilution would become a payment obligation — for a company that used $156.4 million of cash in operations last quarter.
The clause that reveals what the seller thinks of its own payment
Anyone selling goods for paper has a problem: from signing onward they carry the risk of that paper, even though they will not receive it for months. Boeing solved that problem in a way that says more about the seller’s view than any press release does.
Among the termination rights is this one: Boeing may terminate the agreement if Archer’s enterprise value, as calculated under the contract, falls below a minimum level for a specified period. The right lapses five business days after Archer notifies Boeing in writing that the trigger has occurred. In plain language, the seller has hedged itself against a devaluation of precisely the currency it agreed to be paid in. A cash seller has no need of such a clause.
The second tell is in the lock-up. Boeing may not sell or transfer the consideration shares for twelve months. The exceptions, though, are drawn strikingly wide: hedging transactions are expressly permitted, as is pledging the shares as collateral in connection with such a transaction or in a margin account — provided settlement does not require a transfer during the lock-up. The restriction binds the certificates, not the economic exposure.
Then the warrants. The first carries an exercise price of $13.00, exercisable from month twelve to month 36 after closing; the second $17.88, running to month 48. The stock is at $6.26. The 52-week range is $4.30 to $14.62. Boeing’s participation in the upside therefore begins at a price the shares have not seen in a year, and the second tranche strikes above the 52-week high. As a sweetener that is not a gift; it is a bet on a doubling. It is worth noting that Archer’s own legacy warrants from its 2021 listing, still quoted as ACHR WS, carry an $11.50 strike. The company’s entire warrant complex sits well above the market.
What the market would have paid for the package
The price reaction lets you back out what the market assigns to the three businesses. Before the announcement, Archer was worth about $4.25 billion — 759.6 million shares at $5.59. After it, the market is valuing a company that will have 19.75 percent more shares: 909.6 million at $6.26, or roughly $5.69 billion. The difference of about $1.45 billion is what the market implicitly puts on Wisk, Insitu and SkyGrid combined.
Boeing is receiving paper worth roughly $940 million for them. The half-billion gap is the price of not having found a cash buyer.
Two caveats belong with that calculation, and they matter. First, Archer reported second-quarter results the same day — $5 million of revenue, a loss of 25 cents a share, $1.56 billion of liquidity. The move cannot be cleanly split between the numbers and the deal. Second, the market is pricing a closing that has not happened. As an order of magnitude the finding still holds, particularly since Jefferies analysts valued Insitu alone at around $500 million when Boeing first sought buyers in early 2025. That peers did not follow — Joby rose two percent to $8.84, EHang fell one percent — also argues that what was repriced was one transaction, not a sector.
Boeing’s two disposals this year: one for cash, one for paper
The most revealing comparison is in-house. Under chief executive Kelly Ortberg, Boeing sold portions of its Digital Aviation Solutions unit — Jeppesen, ForeFlight, AerData, OzRunways — to private equity firm Thoma Bravo for $10.55 billion in 2025. Entirely in cash. Ortberg framed it as focusing on core businesses, supplementing the balance sheet and prioritising the investment-grade credit rating.
Months later three more subsidiaries go, and not a dollar changes hands. The difference is not negotiating skill; it is the merchandise. Jeppesen was a profitable software business with recurring revenue, the kind of asset buyout firms will borrow against. Wisk was a cash sink Boeing was funding. Boeing had already gone looking for a buyer for Insitu in early 2025, with interest reported from private equity, and no cash deal materialised for a year and a half. How a business is paid for is the most honest verdict the market offers on what it was worth.
Boeing nonetheless engineered its exit well. Through a reciprocal intellectual property licence it retains access to Wisk’s core autonomous flight technology for its own current and next-generation commercial and defence aircraft. It takes a seat on Archer’s board for as long as it holds at least ten percent. And it removes a business that consumed cash on its own books into one where it counts as a growth story. The balance sheet can use the help: $45.9 billion of consolidated debt against $20.0 billion of cash and marketable securities, with second-quarter free cash flow of $631 million — the first positive quarter in more than a year.
The next capital raise is already in the contract
One side agreement, reported as “Boeing will invest up to $55 million in Archer,” rewards closer reading. The Forward Equity Purchase Agreement gives Archer a one-time right to require Boeing to buy up to $55.0 million of stock. But only on a condition: the issuance must be made in connection with an offering to third-party investors expected to yield gross proceeds of at least $400.0 million. And Boeing’s price is the lowest per-share price paid by any of those third-party investors.
Boeing, in other words, is not anchoring a round. It is tagging along at the floor once others carry it. The clause’s real information content lies elsewhere: it discloses that Archer contemplates raising at least $400 million in fresh equity. The window runs to the later of 31 March 2027 or three months after closing. Anyone treating the 19.75 percent as the full dilution bill has not read the footnote.
Where a US investor can actually own this
The awkward truth of the autonomy trade is that most of it is not listed. Anduril, Archer’s partner on the Thunder programme unveiled at Farnborough in July — a Group 5 autonomous attack rotorcraft with first flight planned for 2027 — is private. So the public market offers proxies rather than pure plays: Boeing itself, which now owns a sixth of the buyer; AeroVironment and Kratos for uncrewed systems and jet-powered drones; and the two listed eVTOL names.
Joby is the instructive control case. It reported $2.3 billion of cash, raised 2026 revenue guidance to $115–125 million, has five aircraft flying and twelve more in production, and rose nine percent on its own numbers. Joby is buying its way forward with a balance sheet; Archer is buying its way forward with a share count. Both approaches can work. They fail differently, which is the part worth holding on to: a cash balance runs out on a schedule you can model, while an equity currency stops working the moment the market decides it should.
The case against this reading
The other side has real arguments. In Insitu, Archer is acquiring a business that actually earns money, fields systems in 35 countries and has delivered more than 3,500 uncrewed aircraft. Wisk brings over 1,700 flight tests across six generations and sixteen years; together the parties count close to two million flight hours. That is not vapour — it is certification files, agency relationships and supply chains that money alone does not accelerate. The acquisition extends the Anduril work rather than replacing it.
And paying in one’s own shares is not a vice; it is the rational use of the cheapest capital available. If the market grants a company with $6.9 million of annual revenue a valuation above four billion dollars, then its own stock is objectively the cheapest funding it has — cheaper than any bond, cheaper than any cash raise. Converting that into real, revenue-generating operations is precisely what management should do.
The risks sit elsewhere. Closing depends on the Hart-Scott-Rodino waiting period and on approvals under national security and foreign direct investment rules — no formality for a defence supplier with operations in the United States, Australia, the United Kingdom and the United Arab Emirates. The outside date is 9 May 2027, extendable by three months if only the regulatory condition is outstanding. And once the twelve-month lock-up lapses, an overhang of roughly 150 million shares sits in the market, with the resale registration statement due within ten days of closing.
Three questions for any deal paid in stock
This is not a one-off but a pattern of 2026: companies whose market values bear little relation to their cash flows are exchanging paper for real operating businesses. Whether that ends well is not settled by the headline. It is settled by three questions you can put to any such contract.
First: does the agreement state a price or a percentage? A percentage means the buyer has fixed its dilution and the seller carries all of the price risk. Second: cash or paper? The form of payment is the most honest valuation the market will give you on the asset being sold — and Boeing demonstrated both within a single year. Third: has the seller hedged against its own consideration? A termination right keyed to the buyer’s enterprise value, a lock-up with an explicit hedging carve-out, and warrants that only bite well above the 52-week high add up to a picture.
That picture need not be read as damning. Boeing has shed a business that cost it money, kept the technology through a licence, and will sit on the buyer’s board. Archer has bought revenue, references and an anchor shareholder without touching its cash. Both sides can be satisfied. There is only one thing not to do: treat Monday’s jump as the answer to what these three companies are worth. That answer is not in the contract — and that is the finding.
Try TradingView Free for 30 Days
Plus get a $15 discount on your first subscription through this link.
